By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Food and Drug Administration (FDA) 

5600 Fishers Lane

Rockville  Maryland  20857  U.S.A.
Phone: 888-463-6332 or 1-888-INFO-FDA (1-888-463-6332) Fax:


SEARCH JOBS
FDA Overview:

The Food and Drug Administration is one of the nation's oldest and most respected consumer protection agencies. This presentation will tell you about FDA's responsibilities, the tools we use to fulfill those responsibilities, and our priorities for improving the way we serve the public.

•Stated most simply, FDA's mission is:
- to promote and protect the public health by helping safe and effective products reach the market in a timely way,
- To monitor products for continued safety after they are in use, and
- To help the public get the accurate, science-based information needed to improve health.

FDA's Mission Statement

The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.


Key Statistics


Email:
Ownership: Private

Web Site: FDA
Employees:
Symbol: 
 



Industry
Government






Company News
BIOTRONIK SE & Co.KG Release: FDA Approves Only ICD With Ultra-High Energy On The First Shock 4/17/2015 10:40:41 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Malignant Gliomas 4/17/2015 6:25:59 AM
RXi Pharmaceuticals (RXII) Receives Orphan Drug Designation For Samcyprone From The U.S. FDA For The Treatment Of Malignant Melanoma Stage IIb to IV 4/17/2015 6:18:05 AM
FDA Requests Minor Tweaks to Sunshine Heart's Counter Heart Failure Study Before Resuming Patient Enrollment 4/17/2015 6:03:04 AM
Recent FDA Changes Highlight Importance Of Utilizing EAM/CMMS To Manage Compliance Risks 4/16/2015 12:07:52 PM
Momenta Pharmaceuticals, Inc. (MNTA) Announces FDA Approval Of ANDA For Glatopa (Glatiramer Acetate Injection), The First Substitutable Generic For COPAXONE (Glatiramer Acetate Injection) 20mg 4/16/2015 11:39:21 AM
Momenta Pharmaceuticals, Inc. (MNTA) Announces Conference Call Details Regarding FDA Approval For Glatopa (Glatiramer Acetate Injection) 4/16/2015 11:37:52 AM
Provectus Biopharmaceuticals Inc. Opens Patient Enrollment; Begins Phase 3 International FDA Comparative Clinical Trial Of PV-10 For Melanoma 4/16/2015 11:13:54 AM
SillaJen Announces Agreement With The FDA For A Special Protocol Assessment For Upcoming Phase 3 Pexa-Vec Trial In Advanced Liver Cancer 4/16/2015 11:02:56 AM
TRANSGENE (ENX:TNG): Agreement With FDA Announced For Special Protocol Assessment For Upcoming Phase 3 Pexa-Vec Trial In Advanced Liver Cancer 4/16/2015 10:14:10 AM
12345678910...
//-->